Patents by Inventor Celine DUCLOUX

Celine DUCLOUX has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL HUMAN ERYTHROID PROGENITOR CELL LINE HIGHLY PERMISSIVE TO B19 INFECTION AND USES THEREOF
    Publication number: 20240101958
    Abstract: The present invention concerns a novel human erythroid progenitor cell line, wherein at least 90% of the cells are CD36+ CD44?CD71+; and wherein the cells:—do not express the gene encoding the receptor of Granulocyte-macrophage colony-stimulating factor (GM-CSF-R gene) or express GM-CSF-R gene at a lower level than the cells of human UT-7/Epo-S1 cell line; and—express the gene encoding the receptor of erythropoietin (Epo-R gene). The present invention also concerns the uses thereof for producing, detecting, or quantifying parvovims B19. The present invention allows the use of the cell lines for 1) a highly sensitive B19 infectious particles detection, and, 2) the efficient production of infectious B19 particles.
    Type: Application
    Filed: December 13, 2021
    Publication date: March 28, 2024
    Inventors: Zahra KADRI, Stany CHRETIEN, Emmanuel PAYEN, Bruno YOU, Celine DUCLOUX